Clinical Trials
Showing 11-14 results of 14 total
Cancer
New investigational drug for relapsed or refractory B-cell Non-Hodgkin Lymphoma.
This study will evaluate the safety and anti-cancer activity of Loncastuximab Tesirine in combination with other anti-cancer agents.
Blood Disorders|Cancer
Study of REGN5458 plus Carfilzomib for multiple myeloma.
The primary purpose of this study is to assess the safety and tolerability an investigational drug, REGN5458, combined with the current approved standard of...
Blood Disorders|Cancer
A study for patients with aggressive B-cell non-Hodgkin lymphoma.
This study will evaluate the safety and tolerability of investigational drug IMPT-314. It will also help to determine the recommended phase 2 dosing.
Blood Disorders|Cancer
Study for patients with refractory/relapsed acute myeloid leukemia (AML).
The purpose of this study is to determine the safety and tolerability of the investigational drug BP1002 in participants who have refractory/relapsed AML...